Cleared Traditional

K100011 - FISHER & PAYKEL HEALTHCARE BUBBLE CPAP ...

K100011 is the FDA 510(k) clearance for FISHER & PAYKEL HEALTHCARE BUBBLE CPAP ... by Fisher &Paykel Healthcare , Ltd.. It is a Class 2 Anesthesiology device (product code BZD) cleared through the Traditional 510(k) pathway after a 277-day FDA review.

K100011 · Fisher &Paykel Healthcare , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
277d
Days
Class 2
Risk

K100011 is an FDA 510(k) clearance for the FISHER & PAYKEL HEALTHCARE BUBBLE CPAP SYSTEM. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Fisher &Paykel Healthcare , Ltd. (East Tamaki, Auckland, NZ). The FDA issued a Cleared decision on October 8, 2010 after a review of 277 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fisher &Paykel Healthcare , Ltd. devices

Submission Details

510(k) Number K100011 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 04, 2010
Decision Date October 08, 2010
Days to Decision 277 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
137d slower than avg
Panel avg: 140d · This submission: 277d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 266
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K100011.
MIRAGE FX
K102746 · Resmed, Ltd. · Dec 2010
GOLIFE NASAL MASK
K102502 · Respironics, Inc. · Dec 2010
PIXI PEDIATRIC MASK
K102224 · Resmed, Ltd. · Dec 2010
MIRAGE MICRO MODEL 16333 (S), 16334 (M&L), 16335 (LW & XL)
K100772 · Resmed, Ltd. · Jun 2010
F&P ICON SERIES CPAP
K094040 · Fisher &Paykel Healthcare , Ltd. · Apr 2010
EASYCARE ONLINE
K093684 · Resmed, Ltd. · Feb 2010